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ATR/Chk1 signaling induces autophagy through
sumoylated RhoB-mediated lysosomal
translocation of TSC2 after DNA damage
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DNA damage can induce autophagy; however, the underlying mechanism remains largely
unknown. Here we report that DNA damage leads to autophagy through ATR/Chk1/RhoB-
mediated lysosomal recruitment of TSC complex and subsequent mTORC1 inhibition. DNA
damage caused by ultraviolet light (UV) or alkylating agent methyl methanesulphonate
(MMS) results in phosphorylation of small GTPase RhoB by Chk1. Phosphorylation of RhoB
enhances its interaction with the TSC2, and promotes its sumoylation by PIAS1, which is
required for RhoB/TSC complex to translocate to lysosomes. As a result, mTORC1 is
inhibited, and autophagy is activated. Knockout of RhoB severely attenuates lysosomal
translocation of TSC complex and the DNA damage-induced autophagy. Reintroducing wild-
type but not sumoylation-resistant RhoB into RhoB−/− cells restores the onset of autophagy.
Hence, our study identifies a molecular mechanism for translocation of TSC complex to
lysosomes in response to DNA damage, which depends on ATR/Chk1-mediated RhoB
phosphorylation and sumoylation.
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Autophagy is a self-eating process to remove dysfunctionalor unnecessary proteins and organelles through lysosomaldegradation pathway, and therefore plays an essential role
in maintaining cellular homeostasis1,2. It is a tightly regulated
process involving formation of double-membraned autophago-
some and subsequent conversion to autolysosome by fusing with
lysosome, in which the proteins and organelles are degraded3.
The core machinery of autophagy is orchestrated by a set of
conserved proteins encoded by autophagy-related (ATG) genes,
among which the Atg1/unc-51-like kinase (ULK) kinase complex
functions as the most upstream component that is critical for
initiating autophagosome formation4,5. The mammalian target of
rapamycin (mTOR) complex 1 (mTORC1), a master regulator of
cellular metabolism, inhibits initiation of autophagy by phos-
phorylating ULK1 and autophagy/beclin 1 regulator 1
(AMBRA1) to prevent activation of ULK16. In addition, the
tuberous sclerosis complex (TSC) complex (TSC complex) is the
only known GTPase activating protein (GAP) for the small
GTPase Rheb, a direct activator of mTORC1, and therefore
functions as a key negative regulator for mTORC1 activity7. It has
been shown that TSC complex is recruited to membrane of
lysosomes to regulate Rheb activity, however, the molecular
mechanism for lysosomal membrane recruitment of TSC com-
plex needs to be further elucidated8–10.
DNA damage can trigger various cellular responses
including DNA repair, cell cycle arrest, senescence, apoptosis,
necrosis, and autophagy. The outcome depends on types and
severity of the damage, and death threshold determined by
DNA damage response (DDR) pathways11–13. The
ataxia–telangiectasia mutated (ATM) and ATM-related and
RAD3-related (ATR) kinases compose ATM/Chk2 and ATR/
Chk1 signaling cascades, respectively, which are the two major
pathways in DDR. ATM/Chk2 pathway is activated by double-
strand DNA breaks, whereas ATR/Chk1 signaling is usually
activated by single-stranded DNA or bulky DNA lesions14,15.
It has been reported that DDR signaling can activate autop-
hagy through inhibiting mTORC1 activity via several path-
ways involving ATM, p53, AMP-activated protein kinase
(AMPK), c-Jun N-terminal kinase (JNK), and poly (ADP-
ribose) polymerase-1 (PARP1), etc.12,16–23. However, the
underlying mechanism for DDR-induced autophagy, espe-
cially how ATR/Chk1 signaling triggers autophagy, remains
elusive.
The Rho family small GTPases are key regulators of actin
cytoskeleton24,25. Notably, RhoB exerts distinct roles in various
biological contexts compared with its highly homologous
family member RhoA and RhoC, although they are all involved
in regulating actin dynamics and migration26,27. RhoB is a
short-lived protein and its levels are frequently found
decreased in many types of cancer26,28. Increased RhoB induces
apoptosis in diverse cancer cell lines29–34, while knockout of
RhoB significantly inhibits DNA damage-induced apoptosis35,
suggesting that RhoB suppresses tumorigenesis through pro-
moting cell death. Our previous study showed that E3 ubiquitin
ligase Smurf1 targets RhoB for degradation to maintain a
relative low RhoB level in the basal state. Activation of ATR/
Chk1 signaling upon DNA damage induces self-degradation of
Smurf1, and therefore prevents RhoB from Smurf1-mediated
degradation36.
In this study, we found that RhoB is phosphorylated by Chk1
after DNA damage, which promotes its binding to SUMO E3
ligase PIAS1 and subsequent sumoylation. Meanwhile, this
phosphorylation also enhances the binding of RhoB to TSC
complex. Therefore, the sumoylated phospho-RhoB functions as
a carrier protein to translocate TSC complex to lysosomes,
initiating autophagy by inhibiting mTORC1 activity.
Results
PIAS1 mediates sumoylation of small GTPase RhoB. Our
previous study showed that Smurf1 targets RhoB for ubiquiti-
nation to control its abundance in cells under basal conditions.
Upon DNA damage, ATR/Chk1 signaling triggers Smurf1 self-
degradation and leads to an accumulation of RhoB to promote
apoptosis36. To further investigate the role of RhoB in DDR, we
carried out a yeast-two-hybrid screen using RhoB as the bait to
identify novel RhoB-binding proteins. Interestingly, we found
that among the identified candidates several clones encode
ubiquitin-conjugating enzyme 9 (Ubc9), the only known SUMO-
conjugating E2 enzyme in mammalian cells. To verify this
interaction, we performed coimmunoprecipitation assay (Fig. 1a)
and in vitro GST pull-down assay (Supplementary Fig. 1a),
confirming that RhoB interacts with Ubc9 in cells and in vitro.
We therefore examined whether RhoB could be sumoylated.
We immobilized His-tagged RhoB using Nickel–nitrilotriacetic
acid (Ni-NTA) agarose beads followed by immunoblotting to
detect the conjugation of SUMO. Indeed, we found that RhoB
could be sumoylated with a preference for SUMO2 conjugation,
and coexpression of Ubc9 enhanced RhoB sumoylation (Fig. 1b).
In addition, we carried out in vitro sumoylation assay and
confirmed that Ubc9 could directly target RhoB for SUMO2
conjugation (Supplementary Fig. 1b).
We next examined the effects of PIAS family of SUMO E3
ligases on RhoB sumoylation. As shown in (Fig. 1c), PIAS1 signi-
ficantly enhanced the sumoylation of RhoB, whereas other PIAS
family members did not. Meanwhile, knockdown of endogenous
PIAS1 remarkably inhibited sumoylation of RhoB (Fig. 1d),
indicating that PIAS1 is a major SUMO E3 ligase for RhoB. In
addition, overexpression of wild-type PIAS1 but not PIAS1-
C351S, a catalytic inactive mutant, promoted RhoB sumoylation
(Fig. 1e). Similarly, wild-type PIAS1 but not PIAS1-C351S
increased SUMO-conjugation in the in vitro sumoylation assay
(Supplementary Fig. 1c), indicating that PIAS1-mediated increase
of RhoB sumoylation is dependent on the catalytic activity of
PIAS1. We further confirmed that PIAS1 could interact with
RhoB in cells by trapping endogenous and exogenous RhoB using
catalytically inactive PIAS1-C351S (Fig. 1f; Supplementary
Fig. 1d). Moreover, in vitro GST pull-down assay indicated a
direct interaction between PIAS1 and RhoB (Supplementary
Fig. 1e).
To identify the sumoylation site(s) on RhoB, we carried out
in vitro sumoylation reaction of RhoB to obtain sumoylated RhoB
for mass spectrometry analysis. SUMO-conjugation could be
detected on three lysine residues (Lys7, Lys135, and Lys194) in
RhoB (Supplementary Fig. 1f). Mutations of Lys6 and 7, Lys135,
or Lys194 to arginine (K6, 7R, K135R, or K194R) significantly
decreased sumoylation levels of RhoB, and mutation of all the
four lysine residues to arginines (4KR) nearly completely
abolished the RhoB sumoylation in cells and in vitro (Fig. 1g;
Supplementary Fig. 1g). Accordingly, PIAS1 could only enhance
sumoylation of wild-type RhoB but not RhoB-4KR (Fig. 1h). Of
note, RhoB-4KR and wild-type RhoB showed similar binding
affinity to the Rho-binding domain (RBD) of Rho effector protein
Rhotekin (Supplementary Fig. 1h), and similar effect on
enhancing cell stress fiber formation (Supplementary Fig. 1i),
indicating that RhoB-4KR is folded properly and able to activate
ROCK pathway.
Sumoylation is required for RhoB translocation to lysosomes.
We next explored the upstream signal(s) that can trigger
sumoylation of RhoB in cells. Interestingly, although treatment of
ultraviolet (UV), alkylating agent methyl methanesulphonate
(MMS), topoisomerase I inhibitor camptothecin (CPT), or
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topoisomerase II inhibitor doxorubicin (DOX) all caused severe
DNA damage (Supplementary Fig. 2a), only UV and MMS sig-
nificantly enhanced RhoB sumoylation, indicating a specific effect
of UV or MMS treatment on regulating RhoB sumoylation
(Fig. 2a). Consistent with our previous report36, UV or MMS
treatment strongly activated Chk1, whereas CPT and DOX
treatment mainly activated Chk2 (Supplementary Fig. 2b).
To examine whether endogenous RhoB in cells could be
sumoylated, we exogenously expressed His-tagged SUMO2 in
cells, pull-down His-SUMO2 using Ni-NTA agarose beads, and
immunoblotted RhoB to detect the conjugation of RhoB and
SUMO2. Strikingly, sumoylation of endogenous RhoB could only
be detected after cells were treated with UV or MMS, and, as
indicated, the major conjugation form is mono-sumoylated RhoB
(Fig. 2b). Of note, the levels of endogenous RhoB dramatically
increased in cells treated with UV or MMS (Fig. 2b), which is in
good agreement with our previous study36. It is noteworthy that
UV or MMS treatment significantly enhanced sumoylation of
exogenous His-tagged RhoB, even though the protein levels of
His-RhoB were adjusted to a similar level (Supplementary Fig. 2c),
indicating that the upregulation of endogenous RhoB sumoyla-
tion is not only due to the increase of RhoB protein levels, but
also because of an increased efficiency of sumoylation. As
expected, the 4KR mutation totally abolished the UV or MMS-
induced RhoB sumoylation (Supplementary Fig. 2c).
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We found that UV or MMS treatment dramatically changed
the subcellular localization of RhoB. In cells without treatment,
RhoB mainly localized to plasma membrane and some small
vesicles. Specifically, in cells treated with UV or MMS,
endogenous RhoB exhibited a strong aggregation pattern and
colocalized with LAMP1 (lysosome-associated membrane protein
1) (Fig. 2c; Supplementary Fig. 2d), indicating that RhoB could be
translocated to lysosomes after UV or MMS treatment. In good
agreement with that RhoB sumoylation occurs specifically in
response to UV or MMS treatment (Fig. 2a), treatment with CPT
or DOX did not alter the plasma membrane localization of RhoB
(Fig. 2c; Supplementary Fig. 2d). It is noticeable that although
dissociated from plasma membrane, RhoB-4KR was not translo-
cated to lysosomes (Fig. 2d; Supplementary Fig. 2e). Similarly,
knockdown of PIAS1 did not block the dissociation of RhoB from
plasma membrane after UV or MMS treatment, but significantly
impeded the translocation of RhoB to lysosomes (Supplementary
Fig. 2f, g), indicating that the lysosomal translocation of RhoB is
dependent on the sumoylation.
Sumoylation of RhoB is required for UV/MMS-induced
autophagy. Because lysosomes play essential roles in the process
of autophagy, we hypothesized that RhoB might be involved in
regulating autophagy after DNA damage. To evaluate this, we
first detected the formation of LC3 puncta by fluorescence
microscopy using mCherry red fluorescent protein-tagged LC3
(mRFP-LC3). Indeed, knockout of RhoB markedly decreased
number of mRFP-LC3 puncta in cells treated with UV or MMS
but not in cells treated with CPT or DOX (Fig. 3a; Supplementary
Fig. 3a). In line with the microscopy assay, knockout of RhoB
significantly attenuated the upregulation of LC3-II (autophago-
some-associated form of LC3) and downregulation of p62/
SQSTM1 in cells treated with UV or MMS but not CPT or DOX,
and the presence of lysosome inhibitor chloroquine increased the
LC3-II levels under these conditions (Fig. 3b; Supplementary
Fig. 3b–d), indicating that RhoB positively affects autophagic flux
in response to UV or MMS treatment. Reintroducing wild-type
RhoB but not sumoylation-resistant mutant RhoB-4KR into
RhoB−/− cells restored the UV or MMS-induced LC3 aggregation
(Fig. 3c; Supplementary Fig. 3e). Accordingly, reintroduction of
wild-type RhoB but not RhoB-4KR upregulated LC3-II and
downregulated p62/SQSTM1 (Fig. 3d; Supplementary Fig. 3f).
Moreover, knockdown of PIAS1 significantly blocked UV or
MMS-induced autophagy (Supplementary Fig. 3g–j), confirming
that sumoylation is required for UV or MMS-mediated
autophagy.
We next further evaluated the function of RhoB in regulating
autophagic flux using tandem fluorescent protein-tagged LC3
(mRFP-GFP-LC3) to monitor maturation of autophagosomes
into autolysosomes. In this assay, the fluorescence of GFP is
quenched by the low pH inside autolysosomes, whereas mRFP is
more resistant to the acidic condition37. Hence, both GFP and
RFP fluorescence will exhibit in autophagosomes (yellow puncta),
but only mRFP fluorescent signal can be detected in autolyso-
somes (red puncta). Indeed, knockout of RhoB remarkably
decreased the numbers of both red and yellow puncta in cells
after UV or MMS treatment (Fig. 3e; Supplementary Fig. 3k),
indicating that the formation of both autophagosomes and
autolysosomes is inhibited. Consistently, reintroduction of wild-
type RhoB but not RhoB-4KR in RhoB−/− cells restored both red
and yellow puncta formation upon UV or MMS treatment
(Fig. 3f; Supplementary Fig. 3l), suggesting that sumoylated RhoB
is required for promoting autophagic flux after DNA damage
caused by UV or MMS.
To further verify the role of RhoB in regulating DNA damage-
induced autophagy, we performed electron microscopy to
examine the formation of autophagosomes and autolysosomes
in RhoB+/+ and RhoB−/− cells. In good agreement with the
fluorescence microscopy assay, knockout of RhoB dramatically
decreased the numbers of both autophagosomes (double-
membraned vesicles) and autolysosomes (single-membraned
vesicles) in cells treated with UV or MMS (Fig. 3g; Supplementary
Fig. 3m). Furthermore, reintroduction of wild-type RhoB but not
RhoB-4KR rescued the formation of autophagosomes and
autolysosomes upon UV or MMS treatment (Supplementary
Fig. 3n, o). Hence, these results clearly demonstrated that
sumoylated RhoB plays a pivotal role in mediating autophagy
in response to UV or MMS treatment.
Sumoylation of RhoB is critical for UV/MMS-induced mito-
phagy. Because we observed a significant number of mitochon-
dria enclosed in the autophagosomes and autolysosomes in cells
treated with UV or MMS, we next explored the role of RhoB in
regulating mitophagy in this scenario. For this end, we first
compared mitochondria removal in control and RhoB knockout
cells after UV or MMS treatment. Indeed, knockout of RhoB
markedly blocked the removal of mitochondria in cells treated
with UV or MMS, as shown by immunofluorescence (Fig. 4a) and
immunoblotting analysis (Fig. 4b) for the mitochondrial heat-
shock protein Hsp60. In addition, treatment with lysosome
inhibitor chloroquine prevented the decrease of Hsp60 levels
induced by UV or MMS (Fig. 4c), indicating that the loss of
Hsp60 is through mitophagy. Consistently, reintroduction of
wild-type RhoB but not RhoB-4KR reinstated the clearance
of mitochondria after treatment with UV or MMS (Fig. 4d;
Supplementary Fig. 4a).
Fig. 1 RhoB is sumoylated by PIAS1. a RhoB interacts with Ubc9. HEK293T cells transfected with indicated combinations of Flag-tagged Ubc9 (F-Ubc9) and
HA-tagged RhoB (HA-RhoB) were subjected to anti-Flag immunoprecipitation (IP) followed by immunoblotting assay to detect associated RhoB. b RhoB is
sumoylated. HEK293T transfected with indicated combinations of His-tagged RhoB (His-RhoB), HA-tagged SUMO (HA-SUMO) 1 or 2, and Myc-tagged
Ubc9 (Myc-Ubc9) were lysed with 6M guanidine-HCl followed by Ni-NTA agarose beads pull-down (Ni pull-down) assay. SUMO-conjugated RhoB was
detected by immunoblotting with anti-HA. Conjugation of mono-SUMO and multi-SUMO to RhoB are indicated as RhoB-SUMO and RhoB-(SUMO)n,
respectively. c PIAS1 promotes sumoylation of RhoB. HEK293T cells cotransfected with His-RhoB, HA-SUMO2, and indicated Myc-tagged PIAS (Myc-
PIAS) family member 1–4 were subjected to sumoylation assay as described in panel b. d Knockdown of PIAS1 attenuates RhoB sumoylation.
HEK293T cells transfected with indicated combinations of His-RhoB, HA-SUMO2, and shRNAs against PIAS1 were subjected to sumoylation assay as
described in panel b. e The E3 catalytic activity is required for PIAS1-mediated RhoB sumoylation. HEK293T cells were transfected with His-RhoB, HA-
SUMO2, and Myc-PIAS1 wild-type (WT) or catalytically inactive mutant (C351S) as indicated. The cells were subjected to sumoylation assay as described
in panel b. f PIAS1 interacts with endogenous RhoB. HeLa cells transduced with lentivirus encoding HA-tagged PIAS1-C351S mutant (HA-PIAS1-C351S)
were subjected to anti-RhoB IP followed by immunoblotting with rat anti-HA to detect associated HA-PIAS1-C351S. g Sumoylation sites mapping on RhoB.
HEK293T cells transfected with HA-SUMO2 and indicated His-RhoB mutants were subjected to sumoylation assay as described in panel b. h PIAS1
enhances sumoylation of WT but not 4KR RhoB. HEK293T cells transfected with indicated combinations of HA-SUMO2, Myc-PIAS1 (WT or C351S), and
His-RhoB (WT or 4KR) were subjected to sumoylation assay as described in panel b
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To further verify the effect of RhoB on turnover of
mitochondria in response to UV or MMS-induced DNA damage,
we performed double fluorescence assay using a previous
reported mRFP-GFP-tagged signal peptide (residues 101–152)
of mitochondrial fission 1 protein (mRFP-GFP-FIS1101-152),
which localizes to the outer membrane of mitochondria, to
monitor the delivery of mitochondria to autolysosomes during
mitophagy38. Similar to mRFP-GFP-LC3, mRFP-GFP-FIS1101-152
displayed both red and green fluorescence in autophagosomes but
only red signal in autolysosomes. In line with the results above,
knockout of RhoB remarkably blocked the red-only puncta
formation in cells treated with UV or MMS (Figs. 4e, f), and
reintroduction of wild-type RhoB but not RhoB-4KR restored the
formation of red-only puncta (Supplementary Fig. 4b). Hence,
our results demonstrated that sumoylation of RhoB is also
necessary for UV or MMS-induced mitophagy.
Our previous study showed that RhoB is required for UV or
MMS-induced apoptosis36; therefore, we further investigated
whether sumoylated RhoB-mediated autophagy is required for
the cell death. Consistent with our previous report, knockout of
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Fig. 2 Sumoylated RhoB is translocated to lysosomes. a Sumoylation of RhoB is specific to ultraviolet (UV) or methyl methanesulphonate (MMS)
treatment. One hour after treated with UV (80 Jm−2) or 2 h after treated with MMS (0.5mM), camptothecin (CPT) (10 μM), or doxorubicin (DOX)
(0.5 μM), HEK293T cells expressing HA-SUMO2 and His-RhoB were subjected to sumoylation assay to detect the SUMO2 conjugation of RhoB. b UV or
MMS treatment enhances sumoylation of endogenous RhoB. HeLa cells with expression of His-SUMO2 were subjected to sumoylation assay 2 h after
treated with UV (80 Jm−2) or 4 h after treated with MMS (0.5 mM). SUMO2 conjugation of RhoB was detected by immunoblotting with RhoB antibody.
c Endogenous RhoB colocalizes with LAMP1 after UV or MMS but not CPT or DOX treatment. HeLa cells were subjected to immunofluorescence assay 2 h
after treated with or without UV (80 Jm−2), MMS (0.5 mM), CPT (10 μM), or DOX (0.5 μM). Scale bar, 10 μm. d RhoB WT but not RhoB-4KR colocalizes
with LAMP1 after UV or MMS treatment. U2OS cells expressing HA-RhoB (WT or 4KR) were subjected to immunofluorescence assay 4 h after UV
(80 Jm−2) or MMS (0.5 mM) treatment to examine the localization of HA-RhoB and endogenous LAMP1. Scale bar, 10 μm
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assay 4 h after UV (80 Jm−2) or 6 h after MMS (0.5mM) treatment. The dot lines indicate cells expressing RhoB WT or 4KR. Scale bar, 10 μm.
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but not 4KR promotes the autophagic flux upon UV or MMS treatment. RhoB−/− cells stably expressing mRFP-GFP-LC3 were transduced with HA-RhoB
WT or 4KR. Cells were treated and subjected to immunofluorescence assay as in panel e. The dot lines indicate cells expressing RhoB WT or 4KR. Scale
bar, 10 μm. g Knockout of RhoB attenuates UV or MMS-induced autophagosomes and autolysosomes formation. RhoB+/+ or RhoB−/− cells were assessed
by electron microscopy 6 h after UV (80 Jm−2) or 8 h after MMS (0.5mM) treatment. The magnified images are the areas indicated by the squares. Red
arrow indicates autophagosome/autolysosome with mitochondria
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Fig. 4 Sumoylated RhoB is required for UV or MMS-induced mitophagy and cell death. a and b Knockout of RhoB inhibits mitochondria clearance after UV
or MMS treatment. RhoB+/+ or RhoB−/− cells were treated as Fig. 3e and subjected to immunofluorescence (a) or immunoblotting (b). Scale bar, 10 μm.
c UV or MMS-induced downregulation of Hsp60 is through lysosome pathway. HeLa cells pretreated 1 h with or without 100 μM CQ were treated and
processed as in panel b. d Reintroduction of RhoB WT but not 4KR down-regulates Hsp60 after UV or MMS treatment. RhoB−/− cells transduced with HA-
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test after arcsine transformation and represented as mean ± SD (f). g and h Sumoylated RhoB is required for UV or MMS-induced apoptosis. RhoB+/+ or
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independent experiments were assessed by one-way ANOVA (F(17,36)= 1069.3) followed by LSD post hoc test after arcsine transformation and
represented as mean ± SD
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RhoB dramatically inhibited UV or MMS-induced apoptosis
(Fig. 4g). Interestingly, reintroduction of wild-type but not 4KR
RhoB rescued the apoptosis induced by UV or MMS treatment
(Fig. 4h), suggesting that sumoylation is necessary for RhoB-
mediated cell death. Moreover, double knockout of ULK1/2
significantly attenuated RhoB-promoted apoptosis in response to
UV or MMS treatment (Fig. 4i), indicating autophagy is required
for RhoB to promote cell death upon DNA damage.
ATR/Chk1 signaling is required for UV/MMS-induced autop-
hagy. As we have shown that UV or MMS-induced DDR is
mainly through Chk1 signaling pathway (Supplementary Fig. 2b),
we therefore investigated whether ATR/Chk1 signaling is also
involved in regulating the UV or MMS-triggered autophagy.
Indeed, treated with ATR inhibitor but not ATM inhibitor dra-
matically attenuated UV or MMS-induced puncta formation of
mRFP-LC3 (Fig. 5a, b), suggesting that ATR but not ATM is a
major regulator of UV or MMS-triggered autophagy. Con-
sistently, inhibiting ATR but not ATM strongly blocked UV or
MMS-mediated Chk1 activation (Supplementary Fig. 5a). The
role of ATR in controlling UV or MMS-induced autophagy is also
confirmed by knocking down ATR (Supplementary Fig. 5b–d).
We next examined the necessity of Chk1 in the UV or MMS-
induced autophagy. As predicted, Chk1 but not Chk2 inhibitor
drastically decreased the LC3 aggregation after UV or MMS
treatment (Fig. 5c, d). In addition, knockdown of Chk1 also
markedly attenuated LC3 puncta formation in cells treated with
UV or MMS (Supplementary Fig. 5e–g). Moreover, Chk1
inhibitor significantly blocked the upregulation of LC3-II induced
by UV or MMS treatment (Fig. 5e; Supplementary Fig. 5h). We
further determined the role of Chk1 in regulating autophagic flux
using mRFP-GFP-LC3 and found that knockdown of Chk1
activity dramatically diminished the formation of both red and
yellow puncta in cells treated with UV or MMS (Fig. 5f;
Supplementary Fig. 5i). Thus, these results indicated that ATR/
Chk1 signaling pathway plays a key role in controlling UV or
MMS-induced autophagy.
Phosphorylation of RhoB is essential for its translocation. To
investigate whether ATR/Chk1 signaling-mediated autophagy is
through a RhoB-dependent pathway, we first examined whether
Chk1 activity is necessary for the translocation of RhoB to lyso-
somes. Treatment with Chk1 inhibitor or knockdown of Chk1
remarkably diminished the colocalization between RhoB and
LAMP1 (Fig. 6a; Supplementary Fig. 6a–c), indicating Chk1
activity is required for lysosomal translocation of RhoB. Mean-
while, Chk1 inhibitor efficiently blocked both endogenous and
exogenous RhoB sumoylation induced by UV or MMS (Fig. 6b;
Supplementary Fig. 6d). The upregulation of RhoB by UV or
MMS was also blunted when Chk1 was inhibited (Fig. 6b), which
is consistent with our previous study36. Moreover, using kinase-
dead mutant Chk1-D130A39, we were able to detect its interac-
tion with both exogenous and endogenous RhoB (Fig. 6c; Sup-
plementary Fig. 6e), suggesting that Chk1 may directly target
RhoB for phosphorylation.
Next, we performed in vitro phosphorylation assay and
observed that Chk1 could phosphorylate RhoB on its threonine
but not serine residue(s) by using phospho-Thr and phospho-Ser
specific antibodies (Fig. 6d). We identified that Thr173 and
Thr175 of RhoB was phosphorylated by Chk1 using matrix-
assisted laser desorption/ionization time-of-flight mass spectro-
metry (MALDI-TOF-MS) (Supplementary Fig. 6f). We next used
RhoB-2A, a mutant with Thr173 and Thr175 mutated to alanines,
to perform the in vitro phosphorylation assay. As expected, point
mutations of Thr173 and Thr175 to alanines strongly attenuated
the Chk1-mediated phosphorylation of RhoB (Fig. 6e), confirm-
ing that the Chk1-mediated RhoB phosphorylation is at Thr173
and Thr175 of RhoB.
To investigate the function of Chk1-mediated phosphorylation
of RhoB, we compared the sumoylation and subcellular
localization of wild-type RhoB with nonphospho-mimicking
mutant RhoB-2A (T173A and T175A) and phospho-mimicking
mutant RhoB-2E (T173E and T175E). Remarkably, UV or MMS
treatment drastically enhanced interaction of PIAS1 with wild-
type RhoB. The RhoB-2E mutant, however, showed a strong
interaction with PIAS1 even at basal state, whereas the interaction
between RhoB-2A mutant and PIAS1 remained weak even after
UV or MMS treatment (Fig. 6f; Supplementary Fig. 6g),
indicating that Chk1-mediated phosphorylation of RhoB is
important for its binding to PIAS1. Accordingly, UV or MMS
treatment significantly increased sumoylation of wild-type RhoB
but not RhoB-2A, and RhoB-2E was markedly sumoylated even
without UV or MMS treatment (Fig. 6g). In line with this, RhoB-
2E colocalized with LAMP1 at basal state, and the 2A mutation
abolished the colocalization of RhoB with LAMP1 induced by UV
or MMS treatment (Fig. 6h, Supplementary Fig. 6h). It is
noticeable that RhoB-2E was mainly in the cytosol at basal state
and RhoB-2A retained on plasma membrane even after UV or
MMS treatment, suggesting that the phosphorylation of RhoB is
required for its dissociation from plasma membrane. Moreover,
the 4KR mutation blocked the translocation of RhoB-2E to
lysosomes (Supplementary Fig. 6i, j), further confirming that
sumoylation is critical for lysosomal translocation of RhoB but
not dissociation from plasma membrane.
Sumoylated RhoB recruits TSC complex to lysosomes. We then
sought to investigate how RhoB promotes autophagy in response
to UV or MMS treatment. As shown in Fig. 3, RhoB is required
for the formation of both autophagosomes and autolysosomes,
suggesting RhoB might be involved in initiating autophagy. We
therefore determined the activity of ULK1 by examining its
phosphorylation level. Interestingly, we found that knockout of
RhoB drastically impeded UV-induced or MMS-induced down-
regulation of phosphorylation of ULK1 and ribosomal protein S6
kinase (S6K), a classical substrate of mTORC1 and its phos-
phorylation levels are usually used to reflect mTORC1 activity7
(Fig. 7a), suggesting a critical role of RhoB in inhibiting mTORC1
activity in the context of UV or MMS-induced DNA damage. In
contrast, knockout of RhoB had no effect on CPT or DOX
treatment-induced downregulation of phosphorylation of ULK1
and S6K (Supplementary Fig. 7a), in line with that CPT and DOX
do not promote RhoB sumoylation. Indeed, reintroduction of
wild-type RhoB but not RhoB-4KR into the RhoB−/− cells
restored the downregulation of phospho-ULK1 and phospho-S6K
caused by UV or MMS treatment (Fig. 7b), indicating that
sumoylation is required for RhoB-mediated inhibition of
mTORC1. This was further confirmed by knocking down PIAS1
(Supplementary Fig. 7b).
It is well known that mTORC1 is directly activated by GTP-
bound Rheb, and that TSC complex is the only known GAP for
Rheb; therefore, inhibition of mTORC1 by TSC complex is
through inactivating Rheb7. Recent studies have shown that
recruitment of TSC complex to lysosomes is a general mechanism
to inactivate mTORC1 in response to various cellular stresses9.
Indeed, knockout of TSC2 dramatically blocked UV or MMS
treatment-induced autophagy (Supplementary Fig. 7c–f). We
found that colocalization of endogenous RhoB and TSC2 was
dramatically increased after UV or MMS treatment (Fig. 7c;
Supplementary Fig. 7g). We therefore investigated whether RhoB
is required for the translocation of TSC complex to lysosomes. As
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expected, TSC2 was translocated to lysosomes upon UV or MMS
treatment; however, knockout of RhoB significantly hindered this
translocation (Fig. 7d; Supplementary Fig. 7h). Reintroduction of
wild-type RhoB but not RhoB-4KR into the RhoB−/− cells
restored the lysosomal translocation of TSC2 in response to UV
or MMS treatment (Fig. 7e; Supplementary Fig. 7i). Consistently,
knockdown of PIAS1 also remarkably blocked the translocation
of TSC2 to lysosomes after UV or MMS treatment
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Fig. 5 ATR/Chk1 activity is required for UV or MMS-induced autophagy. a and b ATR but not ATM activity is required for UV or MMS-induced LC3
aggregation. HeLa cells with stable expression of mRFP-LC3 pretreated 0.5 h with or without ATM inhibitor CP-466722 (10 μM) or ATR inhibitor VE-821
(1 μM) were subjected to fluorescence microscopy 4 h after UV (80 Jm−2) or 6 h after MMS (0.5 mM) treatment (a). The numbers of red puncta per cell
were quantified using Imaris x64 image analysis software. Five random areas were counted for each experiment and data are presented as mean ± SD of
three individual experiments. One-way ANOVA (F(8,126)= 165.07) followed by LSD post hoc test for multiple comparisons (b). c and d Chk1 but not
Chk2 activity is required for UV or MMS-induced autophagy. HeLa cells with stable expression of mRFP-LC3 pretreated 0.5 h with or without Chk1 inhibitor
(0.2 μM) or Chk2 inhibitor-II (4 μM) were treated and subjected to fluorescence microscopy as in panel a. Quantification of red puncta per cell was as in
panel b. One-way ANOVA (F(8,126)= 229.17) followed by LSD post hoc test for multiple comparisons. e Treatment with Chk1 inhibitor attenuates UV or
MMS-induced augment of LC3-II. HeLa cells pretreated 0.5 h with or without Chk1 inhibitor (0.2 μM) were subjected to immunoblotting assay 4 h after
treated with UV (80 Jm−2) or 6 h after treated with MMS (0.5 mM). f Knockdown of Chk1 decreases the autophagic flux promoted by UV or MMS
treatment. HeLa cells with stable expression of mRFP-GFP-LC3 and control shRNA (sh-Con) or shRNA against Chk1 (sh-Chk1-1 or sh-Chk1-2) were
subjected to fluorescence microscopy 8 h after treated with UV (80 Jm−2) or 10 h after treated with MMS (0.5 mM). Scale bar, 10 μm
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Fig. 6 Chk1 phosphorylates RhoB to promote its sumoylation and translocation to lysosomes. a Chk1 activity is required for translocation of RhoB to
lysosomes. HeLa cells pretreated 0.5 h with or without Chk1 inhibitor (0.2 μM) were subjected to immunofluorescence assay 2 h after UV (80 Jm−2) or 4 h
after MMS (0.5mM) treatment to examine the localization of endogenous RhoB and LAMP1. Scale bar, 10 μm. b Chk1 activity is essential for UV or MMS-
induced sumoylation of endogenous RhoB. HeLa cells with expression of His-SUMO2 were treated as in panel a and then subjected to sumoylation assay.
SUMO2 conjugation of RhoB was detected by immunoblotting with RhoB antibody. c Chk1 interacts with endogenous RhoB. HeLa cells transduced with
Flag-tagged Chk1-D130A mutant (F-Chk1-D130A) were subjected to anti-RhoB IP followed by immunoblotting with anti-Chk1 to detect associated F-Chk1-
D130A. d Chk1 phosphorylates RhoB at its threonine residues. In vitro kinase assay was carried out as described in Methods. Phosphorylated RhoB was
detected by immunoblotting using phospho-threonine or phospho-serine antibodies. e Chk1 phosphorylates RhoB at Thr173 and Thr175. RhoB WT or
T173,175A mutant (2A) purified from bacteria were used to perform in vitro kinase assay. f Phosphorylation of RhoB by Chk1 promotes its binding to PIAS1.
HEK293T cells with expression of indicated combination of Flag-tagged PIAS1 (F-PIAS1) and HA-tagged wild-type (WT), T173,175E (2E), or T173,175 A
(2A) RhoB were subjected to coimmunoprecipitation assay 1 h after treated with or without UV (80 Jm−2) to detect associated RhoB. g Phosphorylation of
RhoB by Chk1 is required for UV or MMS-induced sumoylation. HEK293T cells with expression of indicated combination of HA-tagged SUMO2 (HA-
SUMO2) and His-tagged RhoB (WT, 2E, or 2A) were subjected to sumoylation assay 1 h after treated with UV (80 Jm−2) or 2 h after treated with MMS
(0.5mM) to detect the SUMO2 conjugation of RhoB. h Chk1-mediated phosphorylation is essential for UV or MMS-induced lysosomal translocation of
RhoB. U2OS cells with expression of HA-tagged RhoB (WT, 2E, or 2A) were subjected to immunofluorescence assay 4 h after treated with UV (80 Jm−2)
or MMS (0.5 mM). Scale bar, 10 μm
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Fig. 7 Phosphorylated and sumoylated RhoB recruits TSC2 to lysosomes to inhibit mTORC1 activity. a Knockout of RhoB prevents UV or MMS-induced
downregulation of phosphorylated ULK1 and S6K. RhoB+/+ or RhoB−/− cells were subjected to immunoblotting assay 2 h after UV (80 Jm−2) or 4 h after
MMS (0.5 mM). b Sumoylation of RhoB is required for UV or MMS-induced downregulation of phosphorylated ULK1 and S6K. RhoB−/− cells transduced
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RhoB and TSC2. Scale bar, 10 μm. d Knockout of RhoB attenuates translocation of TSC2 to lysosomes after UV or MMS treatment. RhoB+/+ or RhoB−/−
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(Supplementary Fig. 7j, k), indicating a pivotal role of sumoyla-
tion in RhoB-mediated translocation of TSC complex to
lysosomes.
Next, we found that the interaction between RhoB and
endogenous TSC2 was significantly enhanced by UV or MMS
treatment, and this interaction was significantly blocked by
cotreatment of Chk1 inhibitor (Fig. 7f). Accordingly, Chk1
inhibitor dramatically blocked UV or MMS-induced decrease in
phosphorylated ULK1 and S6K (Supplementary Fig. 7l). Mean-
while, RhoB-2E strongly interacted with TSC2 even at basal state,
whereas the interaction between TSC2 and RhoB-2A retained at
low level even after UV or MMS treatment (Fig. 7g), indicating
that phosphorylation of RhoB is required for its interaction with
TSC2. Interestingly, wild-type RhoB and RhoB-4KR showed
comparable binding affinity to TSC2 at basal state and after UV
or MMS treatment (Fig. 7h), indicating that the sumoylation of
RhoB does not affect its binding to TSC2. Reintroduction of
RhoB-2E, the phospho-mimicking mutant that will be sumoy-
lated even at basal state (Fig. 6g), into RhoB−/− cells significantly
promotes translocation of TSC2 to lysosomes, whereas reintro-
duction of RhoB-2E-4KR did not rescue the translocation
(Supplementary Fig. 7m, n), indicating that phosphorylation
and sumoylation of RhoB are both required to translocate TSC
complex to lysosomes. Hence, our study demonstrated that
activation of ATR/Chk1 signaling upon DNA damage triggers a
Chk1-mediated phosphorylation of RhoB, which promotes its
binding to TSC2 and sumoylation. The sumoylated RhoB will
then translocate TSC complex to lysosomes to deactivate
mTORC1, thereby initiating autophagy.
Discussion
It is well known that ATM/Chk2 and ATR/Chk1 signaling cas-
cades are two distinct pathways in response to different types of
DNA lesions. ATM-Chk2 pathway is principally activated by
double-strand DNA breaks, whereas ATR/Chk1 is usually acti-
vated by single-strand DNA lesions14,15. Previous studies sug-
gested that reactive oxygen species and reactive nitrogen species
can initiate autophagy through ATM-mediated activation of
AMPK, which in turn inhibits mTORC1 by activating TSC216,40.
However, how ATR is involved in regulating autophagy is not
clear yet. In this study, we identified a mechanism for ATR/Chk1
signaling-induced autophagy, in which activation of ATR/Chk1
by DNA damage promotes RhoB phosphorylation and sub-
sequent sumoylation, leading to the translocation of TSC complex
to lysosomes to inhibit mTORC1 activity, thereby initiating
autophagy. The phosphorylation of RhoB is mainly required for
its dissociation from the plasma membrane and further interac-
tion with PIAS1 and TSC2, whereas the sumoylation of RhoB is
indispensable for its capability of translocating TSC2 to lyso-
somes. It is well known that sumoylation plays an important role
in regulating protein trafficking41,42; however, how phosphor-
ylation results in dissociation of RhoB from plasma membrane is
unclear. The plasma membrane localization of RhoB is dependent
on the post-translational lipid modifications at its C-terminal43, it
is possible that phosphorylation of RhoB affects the lipid mod-
ifications by a yet to be identified mechanism. Our previous study
showed that downregulation of Smurf1 and the resultant upre-
gulation of RhoB is a specific event downstream of ATR/
Chk1 signaling pathway under DNA damage stress36. Therefore,
the ATR/Chk1 signaling regulates RhoB at two different levels.
On one hand, ATR/Chk1 stabilizes RhoB through inactivation of
Smurf1; on the other hand, it phosphorylates RhoB and promotes
RhoB sumoylation for further translocation of TSC complex to
lysosomes to inhibit mTORC1 and initiate autophagy.
Recent studies showed that depletion of growth factors or
amino acids results in a translocation of TSC1/2 complex to
lysosomal surface to inhibit mTORC1 activity8,10, and lysosomal
recruitment of TSC2 also happens upon different cellular stresses
including hyperosmotic stress, pH stress, hypoxic stress, etc.9. It
was suggested that although lysosomal relocalization of TSC
complex could be a general response to different stresses, the
underlying molecular mechanism for regulating the localization
of TSC complex may vary from stress to stress. However, the
molecular mechanisms by which TSC complex is recruited to
lysosomes in response to these stresses remain largely unknown9.
In this study, we found that DNA damage caused by UV or MMS
treatment also recruits TSC2 to lysosomes. More importantly, we
revealed a unique mechanism of sumoylated RhoB-mediated
lysosomal translocation of TSC2 in response to DNA damage.
The sumoylation of RhoB is only promoted by UV or MMS-
induced DNA damage, but not CPT or DOX-induced double-
strand DNA damage (Fig. 2a), indicating that different stresses
indeed work through distinct pathways to regulate the subcellular
localization of TSC complex. Further study to elucidate the
molecular mechanisms for spatial control of TSC complex loca-
lization under different stresses will be of great interest and
importance to a deeper understanding of how mTORC1 activity
is manipulated in response to various stimuli.
Autophagy primarily acts as a protective mechanism for cell
survival in response to various stresses including nutrient star-
vation, growth factor deprivation, reactive oxygen species,
hypoxia, damaged organelles, protein aggregation, and DNA
damage44. Nevertheless, increasing evidence indicates that
excessive autophagy above certain threshold eventually leads to
programmed cell death12,45. However, how the extent of autop-
hagy is regulated under these stresses is still elusive. RhoB is
recognized as a tumor suppressor due to its role in regulating cell
cycle and apoptosis26. Our previous study showed that accumu-
lation of RhoB by ATR/Chk1-promoted self-degradation of
Smurf1, a major E3 ubiquitin ligase responsible for RhoB turn-
over, is required for UV or MMS-triggered apoptosis36. Inter-
estingly, we observed that the activity of RhoB for enhancing cell
death after UV or MMS treatment is largely dependent on its
capability of promoting autophagy. Ablating sumoylation of
RhoB blocked translocation of RhoB to lysosomes and simulta-
neously prohibited RhoB-elevated cell death after DNA damage.
Meanwhile, double knockout of ULK1/2 remarkably abolished the
RhoB-promoted cell death, suggesting that RhoB-mediated
apoptosis might be through an autophagy-dependent pathway.
In fact, recent studies indicate that autophagy may either directly
mediate cell death or facilitate activation of apoptosis46. Hence,
further scrutinize the relationship between the RhoB-mediated
autophagy and RhoB-mediated apoptosis in response to ATR/
Chk1 signaling may bring new insights into understanding the
molecular mechanisms underlying the interplay between autop-
hagy and apoptosis.
Methods
DNA constructs. Human RhoB constructs (wild-type and K6,7R) have been pre-
viously described36. The cDNAs for UBC9, SUMO1/2, PIAS1/2/3/4, SAE1, UBA2,
FIS1, LC3B, and TSC2 were generous gifts from Dr. J.Han. RhoB mutants (K135R,
K194R, 4KR, T173, 175A, T173, 175E) were generated by PCR-based site-directed
mutagenesis. Cloning for protein expression in mammalian cells was carried out
using a modified pCMV5 vector for transfection, pBOBI and pCDH-EF1-MCS-
IRES-puro vectors for lentivirus infection. pET28a-E1/E2/S2 plasmid was generated
according to previous report except pET28a vector was used instead of pT-Trx47.
The lentivirus-based vector pLL3.7 was used for expression of shRNA. The
sequences for ATR shRNA, Chk1 shRNA-1 and -2, and control shRNA have been
described in previous report36. The sequences used for PIAS1 shRNA-1 and -2 are
5′-GCTCCATATGAACACCTTA-3′ and 5′-AGATGTTTCTTGATCAGTT-3′,
respectively.
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Antibodies and chemical reagents. Mouse anti-actin (1:2000, sc-47778), anti-
Myc (1:2000, sc-40), anti-RhoB (1:1000, sc-8048), anti-GST (1:2000, sc-138), anti-
UBC9 (1:2000, sc-271057), anti-LAMP1 (1:200, sc-20011), anti-tuberin (1:1000, sc-
271314), rabbit anti-Chk1 (1:1000, sc-7898), and rabbit anti-RhoB (1:1000, sc-180)
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA);
mouse anti-HSP60 (1:200, H3524) and anti-FLAG (M2) (1:2000, F1804) antibodies
were purchased from Sigma-Aldrich (St Louis, MO, USA); rabbit anti-TSC2
(1:1000, #4308), anti-ULK1 (1:1000, #8054), anti-AMPKα (1:1000, #2532), anti-
PIAS1 (1:1000, #3550), anti-p70S6 kinase (1:1000, #2708), anti-phospho-p70S6
kinase (1:1000, #9205), anti-phospho-ULK1 (1:1000, Ser757#14202), anti-
phospho-AMPKα (1:1000, Thr172#2531), anti-HSP60 (1:1000, #4870), anti-
phospho-Threonine (1:1000, #9381), anti-Chk2 (1:1000, #2662), anti-Phospho-
Chk1 (1:1000, ser345, #2348), and anti-Phospho-Chk2 (1:1000, Thr68, #2661)
antibodies were purchased from Cell Signaling Technology; mouse anti-SQSTM1/
P62 (1:1000, ab56416) antibody was purchased from Abcam; rat anti-HA (1:2000,
#11867431001) monoclonal antibody was purchased from Roche (Mannheim,
Germany); rabbit anti-LC3B/MAP1LC3B (1:1000, NB100-2220) was purchased
from Novus; mouse anti-phosphoserine (1:1000, #05-1000), mouse anti-phospho-
Histone H2A.X (Ser139)(1:200, #05-636) were purchased from Millipore; rabbit
anti-RhoB (1:1000, 14326-1-AP) and rabbit anti-ATR (1:1000, 19787-1-AP) were
purchased from Proteintech; inhibitors for Chk1 (#681637) and Chk2 (#220485)
were purchased from Calbiochem; inhibitors for ATM CP-466722(#11002) and
ATR VE-821(#14731) were purchased from MedChemExpress; chloroquine,
methyl methanesulphonate, guanidine hydrochloride, and urea were purchased
from Sigma-Aldrich (St Louis, MO, USA); Doxorubicin (HY-15142) and Cam-
pathecin (HY-16560) were purchased from MedChemExpress. All the original
blots with size markers are available in the Supplementary Information.
Cell culture, transfection, and lentivirus infection. Human embryonic kidney
HEK293T, human cervical cancer HeLa, and human osteosarcoma U2OS were
obtained from ATCC. ULK1/2+/+ and ULK1/2−/−MEF cells were a kind gift from
Dr. S.C. Lin; TSC2+/+, and TSC2−/− MEF cells were a kind gift from Dr. Q. Wu.
The cells were cultured in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) (Thermo) and
100 units/ml streptomycin and penicillin (Millipore) at 37°C in a humidified 5%
CO2 incubator. The cell lines were routinely tested and found negative for
mycoplasma. Transient transfection of HEK293T cells was performed as previously
described48. Infection of HeLa, U2OS, and MEF cells were carried out using
recombinant lentivirus generated through the ViraPower Lentiviral Expression
System (Invitrogen).
Generation of RhoB knockout cell line. HeLa cells were used to generate RhoB
knockout cell line using pX330 CRISPR/Cas949 vector. The gene-specific region of
the gRNA sequences were designed by the CRISPR design tool from Zhang lab
(http://crispr.mit.edu/) and the two gRNA sequences RhoB-1 and -2 are 5′-
CTTGCGCCAGGACTTGGCGT-3′ and 5′-GAGCAGCGCGGCGAGACGCA-3′,
respectively. The pX330 empty vector was used as control. Single clones were
picked up and the efficiency of RhoB knockout was assessed by western blot.
Immunoprecipitation, immunoblotting, and GST pull-down assays. Immuno-
precipitation, immunoblotting, GST pull-down assays were performed as pre-
viously described48. Briefly, cells were lysed on ice with lysis buffer TNTE 0.5%
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, and 0.5% Triton X-100,
containing 10 μg/ml pepstatin A, 10 μg/ml leupeptin, and 1 mM PMSF) and then
applied to immunoprecipitation or immunoblotting assays with appropriate anti-
bodies. For GST pull-down assay, bacterially expressed GST-RhoB, GST-Ubc9,
GST-PIAS1, and GST-RBD were purified using glutathione sepharose beads in
TNTE 0.5% buffer. Free Ubc9 and PIAS1 proteins were obtained by tobacco etch
virus (TEV) protease cleavage. Uncropped scans have been included in the Sup-
plementary file (Supplementary Fig. 8).
In vivo and in vitro sumoylation assays. The in vivo sumoylation assay was
carried out as previously described50. Briefly, cells were lysed with the lysis buffer
(6M guanidine-HCl, 0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris/HCl, pH 8.0, 5 mM
imidazole, 20 mM N-ethylmaleimide, and 10 mM β-mercaptoethanol). The lysates
were sonicated and centrifuged at 135,00 g at room temperature for 15 min to
collect supernatant. The supernatant was incubated with Ni2+-NTA-agarose beads
at 4°C overnight. The beads was washed thoroughly and boiled with loading buffer
before applied to immunoblotting assay.
For in vitro sumoylation assay, the plasmids pET28a-E1/E2/S2 and pGEX-RhoB
(WT or 4KR) were simultaneously introduced into E. coli BL21 with selection of both
Ampicilin and Kanamycin based on previous report47. The bacterial lysate was
subjected to GST pull-down followed by western blot to detect the sumoylated RhoB.
In vitro kinase assay. HEK293T cells transfected with triple Flag-tagged wild-type
Chk1 or its dominant negative form Chk1-D130A were pretreated with UV (80 J/m2)
and subjected to immunoprecipitation with anti-Flag antibody 2 h later, followed by
washing twice with 0.5% TNTE and twice with kinase reaction buffer (20mM Tris-
HCl pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 25 µM ATP). Wild-type or mutant
RhoB purified from bacteria was incubated with Chk1 in a total volume of 20 µl of
reaction buffer at 37 °C for 30min before subjected to immunoblotting assay.
Immunofluorescence assay. Cells grown on glass coverslips were washed three
times with phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde and
permeabilized with methanol at −20 °C. The cells were then stained using
appropriate primary and fluorescently conjugated secondary antibodies. Secondary
antibodies used for this assay were Alexa Fluor 405 or 555-conjugated donkey anti-
mouse, Alexa Fluor 488-conjugated donkey anti-rabbit, and Alexa Fluor 488 or
647-conjugated donkey anti-rat secondary antibodies (Invitrogen). Texas Red
conjugated Phalloidin was used for F-actin staining. Images were obtained using a
ZEISS LSM 780 confocal microscope with ZEN 2010 software (Carl Zeiss GmbH,
Jena, Germany) or a Leica TCS SP8 confocal microscope with LAS AF software
(Leica, Germany).
Transmission electron microscopy. HeLa cells were fixed with 2.5% glutar-
aldehyde in 0.1 M PBS (pH 7.4) at 4 °C for 2.5 h, washed three times with 0.1 M
PBS and post-fixed in 1% OsO4 at 4 °C for 2 h. The samples were subsequently
dehydrated in an ethanol gradient (30% (v/v) ethanol (15 min), 50% (v/v) ethanol
(15 min), 70% (v/v) ethanol (15 min), 90% (v/v) ethanol (15 min), and 100%
ethanol (2 × 20 min)) and embedded in Spurr’s resin. Ultrathin (60 nm) sections
were then collected on a copper grid, stained with either uranyl acetate or lead
citrate and examined by a JEM2100HC transmission electron microscope
(Hitachi).
UV irradiation and MMS treatment. UV irradiation and MMS treatment were
performed as previously described36. Briefly, cells were exposed to UV (80 Jm−2) in
Spectrolinker XL-1000 (Spectronics) and then incubated in the original medium
for determined time. For MMS treatment, cells were treated with 0.5 mM MMS for
determined time before subjected to further analysis.
Apoptosis assay. Apoptosis assay was performed as previously described36.
Briefly, cells treated with UV or MMS were collected and washed in PBS
before fixed with 70% ethanol overnight. Fixed cells were washed and incubated
with 100 U ml−1 RNaseA in PBS at 37oC for 30 min, and then stained with
50 mgml−1 propidium iodide in PBS for another 30 min at 37oC in the dark. The
percentages of apoptotic cells were determined by calculating sub-G1 proportion of
cells using a Beckman Coulter FC500 flow cytometer (Beckman Coulter, India-
napolis, IN, USA).
Microscopic data analysis. Punctum formation was assessed by using Imaris x64
image analysis software (version 7.2.3, Bitplane). In brief, distinct puncta were
identified using the spot-create function. All images were batch analyzed using the
same threshold. In autophagy flux assay using mRFP-GFP-LC3, puncta with both
red and green fluorescence that appeared yellow in merged images were counted as
autophagosomes; and puncta appeared red in merged images were counted as
autolysosomes.
Statistical analysis. One-way ANOVA with LSD post hoc test was used to
compare values among different experimental groups using the SPSS Statistics 18.0
program. p < 0.05 was considered a statistically significant change. *p < 0.05; **p <
0.01; ***p < 0.001; NS, not significant. All the values were presented as mean ± SD
of at least triplicate experiments.
Data availability
All data supporting the findings of this study are available within the article and its
Supplementary Information files or from the corresponding author upon request.
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